193 related articles for article (PubMed ID: 38605339)
21. What benefit can be obtained from magnetic resonance imaging diagnosis with artificial intelligence in prostate cancer compared with clinical assessments?
Zhao LT; Liu ZY; Xie WF; Shao LZ; Lu J; Tian J; Liu JG
Mil Med Res; 2023 Jun; 10(1):29. PubMed ID: 37357263
[TBL] [Abstract][Full Text] [Related]
22. Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference.
Vargas HA; Hötker AM; Goldman DA; Moskowitz CS; Gondo T; Matsumoto K; Ehdaie B; Woo S; Fine SW; Reuter VE; Sala E; Hricak H
Eur Radiol; 2016 Jun; 26(6):1606-12. PubMed ID: 26396111
[TBL] [Abstract][Full Text] [Related]
23. Comparison of T2-Weighted Imaging, DWI, and Dynamic Contrast-Enhanced MRI for Calculation of Prostate Cancer Index Lesion Volume: Correlation With Whole-Mount Pathology.
Sun C; Chatterjee A; Yousuf A; Antic T; Eggener S; Karczmar GS; Oto A
AJR Am J Roentgenol; 2019 Feb; 212(2):351-356. PubMed ID: 30540213
[TBL] [Abstract][Full Text] [Related]
24. Development and Validation of an Artificial Intelligence-Powered Platform for Prostate Cancer Grading and Quantification.
Huang W; Randhawa R; Jain P; Iczkowski KA; Hu R; Hubbard S; Eickhoff J; Basu H; Roy R
JAMA Netw Open; 2021 Nov; 4(11):e2132554. PubMed ID: 34730818
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a Deep Learning-based Algorithm for Post-Radiotherapy Prostate Cancer Local Recurrence Detection Using Biparametric MRI.
Yilmaz EC; Harmon SA; Belue MJ; Merriman KM; Phelps TE; Lin Y; Garcia C; Hazen L; Patel KR; Merino MJ; Wood BJ; Choyke PL; Pinto PA; Citrin DE; Turkbey B
Eur J Radiol; 2023 Nov; 168():111095. PubMed ID: 37717420
[TBL] [Abstract][Full Text] [Related]
26. A Workflow to Improve the Alignment of Prostate Imaging with Whole-mount Histopathology.
Yamamoto H; Nir D; Vyas L; Chang RT; Popert R; Cahill D; Challacombe B; Dasgupta P; Chandra A
Acad Radiol; 2014 Aug; 21(8):1009-19. PubMed ID: 25018073
[TBL] [Abstract][Full Text] [Related]
27. Independent real-world application of a clinical-grade automated prostate cancer detection system.
da Silva LM; Pereira EM; Salles PG; Godrich R; Ceballos R; Kunz JD; Casson A; Viret J; Chandarlapaty S; Ferreira CG; Ferrari B; Rothrock B; Raciti P; Reuter V; Dogdas B; DeMuth G; Sue J; Kanan C; Grady L; Fuchs TJ; Reis-Filho JS
J Pathol; 2021 Jun; 254(2):147-158. PubMed ID: 33904171
[TBL] [Abstract][Full Text] [Related]
28. Is there an additional value of ¹¹C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules?
Van den Bergh L; Koole M; Isebaert S; Joniau S; Deroose CM; Oyen R; Lerut E; Budiharto T; Mottaghy F; Bormans G; Van Poppel H; Haustermans K
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1486-92. PubMed ID: 22284686
[TBL] [Abstract][Full Text] [Related]
29. An artificial intelligence algorithm for prostate cancer diagnosis in whole slide images of core needle biopsies: a blinded clinical validation and deployment study.
Pantanowitz L; Quiroga-Garza GM; Bien L; Heled R; Laifenfeld D; Linhart C; Sandbank J; Albrecht Shach A; Shalev V; Vecsler M; Michelow P; Hazelhurst S; Dhir R
Lancet Digit Health; 2020 Aug; 2(8):e407-e416. PubMed ID: 33328045
[TBL] [Abstract][Full Text] [Related]
30. PI-RADS
Yu R; Jiang KW; Bao J; Hou Y; Yi Y; Wu D; Song Y; Hu CH; Yang G; Zhang YD
Br J Cancer; 2023 Apr; 128(6):1019-1029. PubMed ID: 36599915
[TBL] [Abstract][Full Text] [Related]
31. Clinical Validation of Artificial Intelligence-Augmented Pathology Diagnosis Demonstrates Significant Gains in Diagnostic Accuracy in Prostate Cancer Detection.
Raciti P; Sue J; Retamero JA; Ceballos R; Godrich R; Kunz JD; Casson A; Thiagarajan D; Ebrahimzadeh Z; Viret J; Lee D; Schüffler PJ; DeMuth G; Gulturk E; Kanan C; Rothrock B; Reis-Filho J; Klimstra DS; Reuter V; Fuchs TJ
Arch Pathol Lab Med; 2023 Oct; 147(10):1178-1185. PubMed ID: 36538386
[TBL] [Abstract][Full Text] [Related]
32. Ex vivo MRI evaluation of prostate cancer: Localization and margin status prediction of prostate cancer in fresh radical prostatectomy specimens.
Heidkamp J; Hoogenboom M; Kovacs IE; Veltien A; Maat A; Sedelaar JPM; Hulsbergen-van de Kaa CA; Fütterer JJ
J Magn Reson Imaging; 2018 Feb; 47(2):439-448. PubMed ID: 28580659
[TBL] [Abstract][Full Text] [Related]
33. An update on prostate biopsy in the era of magnetic resonance imaging.
Cicione A; De Nunzio C; Manno S; Damiano R; Posti A; Lima E; Tubaro A; Balloni F
Minerva Urol Nefrol; 2018 Jun; 70(3):264-274. PubMed ID: 29595039
[TBL] [Abstract][Full Text] [Related]
34. A systematic review and meta-analysis of artificial intelligence diagnostic accuracy in prostate cancer histology identification and grading.
Morozov A; Taratkin M; Bazarkin A; Rivas JG; Puliatti S; Checcucci E; Belenchon IR; Kowalewski KF; Shpikina A; Singla N; Teoh JYC; Kozlov V; Rodler S; Piazza P; Fajkovic H; Yakimov M; Abreu AL; Cacciamani GE; Enikeev D;
Prostate Cancer Prostatic Dis; 2023 Dec; 26(4):681-692. PubMed ID: 37185992
[TBL] [Abstract][Full Text] [Related]
35. A comprehensive comparison between mpMRI of the prostate, MR-US fusion biopsy and whole mount histopathology.
Doblhammer S; Kinger P; Starmuehler M; Muschitz C; Schima W; Susani M; Baierl A; Broessner C
World J Urol; 2023 Apr; 41(4):1055-1060. PubMed ID: 36840753
[TBL] [Abstract][Full Text] [Related]
36. The added value of AI-based computer-aided diagnosis in classification of cancer at prostate MRI.
Liu G; Pan S; Zhao R; Zhou H; Chen J; Zhou X; Xu J; Zhou Y; Xue W; Wu G
Eur Radiol; 2023 Jul; 33(7):5118-5130. PubMed ID: 36725719
[TBL] [Abstract][Full Text] [Related]
37. Prostate Microstructure in Prostate Cancer Using 3-T MRI with Diffusion-Relaxation Correlation Spectrum Imaging: Validation with Whole-Mount Digital Histopathology.
Zhang Z; Wu HH; Priester A; Magyar C; Afshari Mirak S; Shakeri S; Mohammadian Bajgiran A; Hosseiny M; Azadikhah A; Sung K; Reiter RE; Sisk AE; Raman S; Enzmann DR
Radiology; 2020 Aug; 296(2):348-355. PubMed ID: 32515678
[TBL] [Abstract][Full Text] [Related]
38. Interreader agreement of PI-RADS v. 2 in assessing prostate cancer with multiparametric MRI: A study using whole-mount histology as the standard of reference.
Girometti R; Giannarini G; Greco F; Isola M; Cereser L; Como G; Sioletic S; Pizzolitto S; Crestani A; Ficarra V; Zuiani C
J Magn Reson Imaging; 2019 Feb; 49(2):546-555. PubMed ID: 30187600
[TBL] [Abstract][Full Text] [Related]
39. Applications of Artificial Intelligence in PSMA PET/CT for Prostate Cancer Imaging.
Lindgren Belal S; Frantz S; Minarik D; Enqvist O; Wikström E; Edenbrandt L; Trägårdh E
Semin Nucl Med; 2024 Jan; 54(1):141-149. PubMed ID: 37357026
[TBL] [Abstract][Full Text] [Related]
40. Characterization of clinical human prostate cancer lesions using 3.0-T sodium MRI registered to Gleason-graded whole-mount histopathology.
Broeke NC; Peterson J; Lee J; Martin PR; Farag A; Gomez JA; Moussa M; Gaed M; Chin J; Pautler SE; Ward A; Bauman G; Bartha R; Scholl TJ
J Magn Reson Imaging; 2019 May; 49(5):1409-1419. PubMed ID: 30430700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
